Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

ImmuneBiotech Medical Sweden AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 1,897 Less Arrow 1,612 Less Arrow 1,195
Financial expenses 0 Equal arrow 0 More Arrow 9
Earnings before taxes -5,008 More Arrow -3,862 Less Arrow -4,093
EBITDA -5,160 More Arrow -3,787 Less Arrow -3,969
Total assets 9,984 More Arrow 14,874 Less Arrow 5,478
Current assets 9,949 More Arrow 14,751 Less Arrow 5,249
Current liabilities 560 Less Arrow 516 Less Arrow 346
Equity capital 9,424 More Arrow 14,358 Less Arrow 5,132
- share capital 50 Less Arrow 49 Equal arrow 49
Employees (average) 3 Less Arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 94.4% More Arrow 96.5% Less Arrow 93.7%
Turnover per employee 632 More Arrow 806 More Arrow 1,195
Profit as a percentage of turnover -264.0% More Arrow -239.6% Less Arrow -342.5%
Return on assets (ROA) -50.2% More Arrow -26.0% Less Arrow -74.6%
Current ratio 1776.6% More Arrow 2858.7% Less Arrow 1517.1%
Return on equity (ROE) -53.1% More Arrow -26.9% Less Arrow -79.8%
Change turnover 277 More Arrow 514 More Arrow 692
Change turnover % 17% More Arrow 47% More Arrow 138%
Chg. No. of employees 1 Equal arrow 1 Less Arrow 0
Chg. No. of employees % 50% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.